We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bronchiolitis obliterans (BO) is one of the late-onset noninfectious pulmonary complications that occur after allogeneic HSCT and is usually resistant to immunosup-pressive therapy. A 17-year-old girl with acute lymphoblastic leukemia (ALL) had undergone allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling in 1997. Five years later, she relapsed with ALL and was treated with chemotherapy following stem cell rescue and donor lymphocyte infusion from the original BMT donor. Eight months later, BBO resistant to immunosuppressive therapies, including rituximab, developed in combination with chronic graft-versus-host disease (GVHD). In February 2004, the patient underwent LDLLT from 2 other family members who were mismatched at 3 HLA loci. The patient has been in good health for more than 30 months following LDLLT and shows no sign of BBO in the transplanted lungs, just as with other patients who have undergone lung transplantation for BO associated with chronic GVHD. LDLLT may therefore be considered a viable therapeutic option for the treatment of BO after allogeneic HSCT.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Krowka MJ, Rosenow EC 3rd, Hoagland HC. Pulmonary complications of bone marrow transplantation.Chest. 1985;87: 237–246.
Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation.Chest. 1996;109:1066–1077.
Chan CK, Hyland RH, Hutcheon MA. Pulmonary complications following bone marrow transplantation.Clin Chest Med. 1990;11:323–332.
Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.Br J Haematol. 1998;100:680–687.
Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.Bone Marrow Transplant. 2001;28:425–434.
Duncker C, Dohr D, Harsdorf S, et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome.Bone Marrow Transplant. 2000;25:1263–1268.
Sakaida E, Nakaseko C, Harima A, et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.Blood. 2003;102: 4236–4242.
Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.Biol Blood Marrow Transplant. 2003;9:657–666.
Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG.Blood. 1988;72:621–627.
Paz HL, Crilley P,Topolsky DL, Coll WX, Patchefsky A, Brodsky I. Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning.Respiration. 1993;60:109–114.
Takeuchi J, Kyo T, Naito K, Sao H, et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.Leukemia. 2002;16:1259–1266.
Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.Biol Blood Marrow Transplant. 2003;9: 505–511.
DeMeo DL, Ginns LC. Clinical status of lung transplantation.Transplantation. 2001;72:1713–1724.
Cohen RG, Starnes VA. Living donor lung transplantation.World J Surg.2001;25:244–250.
Inoue K, Ogawa H, Yamagami T, et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels.Blood. 1996;88:2267–2278.
Yokoi T, Hirabayashi N, Ito M, et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group.Virchows Arch. 1997;431:275–282.
Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients.Eur Respir J. 1995;8:551–558.
Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course.Ann Intern Med. 1989;111:368–376.
Yousem SA.The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients.Hum Pathol. 1995;26:668–675.
Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation.Chest. 1992;101:775–778.
Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.Bone Marrow Transplant. 2005;35:1195–1200.
Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with a prior bone marrow transplant.Chest. 1992;102:948.
Boas SR, Noyes BE, Kurland G, Armitage J, Orenstein D. Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation.Chest. 1994;105:1584–1586.
Gascoigne A, Corris P. Lung transplants in patients with prior bone marrow transplants.Chest. 1994;105:327.
Svendsen UG, Aggestrup S, Heilmann C, et al. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow.Eur Respir J. 1995;8:334–337.
Rabitsch W, Deviatko E, Keil F, et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation.Transplantation. 2001;71:1341–1343.
Heath JA, Kurland G, Spray TL, et al. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience.Transplantation. 2001;72:1986–1990.
Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation.Ann Thorac Surg. 2005;79:1051–1052.
Pechet TV, de le Morena M, Mendeloff EN, Sweet SC, Shapiro SD, Huddleston CB. Lung transplantation in children following treatment for malignancy.J Heart Lung Transplant. 2003;22: 154–160.
Veeken C, Palmer SM, Davis RD, Grichnik KP. Living-related lobar lung transplantation.J Cardiothorac Vasc Anesth. 2004;18:506–511.
Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.Chest. 1984;86:824–829.
Al-Githmi I, Batawil N, Shigemura N, et al. Bronchiolitis obliterans following lung transplantation.Eur J Cardiothorac Surg. 2006;30:846–851.
About this article
Cite this article
Okumura, H., Ohtake, S., Ontachi, Y. et al. Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?. Int J Hematol 86, 369–373 (2007). https://doi.org/10.1532/IJH97.07045
- Living-donor lung transplantation
- Bronchiolitis obliterans (BO)
- Allogeneic hematopoietic stem cell transplantation
- Graft-versus-host disease (GVHD)